Geode Capital Management’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $717K | Sell |
|
|||||
|
2025
Q1 | $2.16M | Buy |
|
|||||
|
2024
Q4 | $3.98M | Buy |
|
|||||
|
2024
Q3 | $4.76M | Sell |
|
|||||
|
2024
Q2 | $5.46M | Buy |
|
|||||
|
2024
Q1 | $20.5M | Buy |
|
|||||
|
2023
Q4 | $19M | Buy |
|
|||||
|
2023
Q3 | $23.8M | Buy |
|
|||||
|
2023
Q2 | $30.1M | Buy |
|
|||||
|
2023
Q1 | $15.4M | Buy |
|
|||||
|
2022
Q4 | $17.3M | Buy |
|
|||||
|
2022
Q3 | $18.1M | Buy |
|
|||||
|
2022
Q2 | $22M | Buy |
|
|||||
|
2022
Q1 | $30.7M | Buy |
|
|||||
|
2021
Q4 | $55.6M | Buy |
|
|||||
|
2021
Q3 | $42.8M | Buy |
|
|||||
|
2021
Q2 | $23.6M | Buy |
|
|||||
|
2021
Q1 | $15.9M | Buy |
|
|||||
|
2020
Q4 | $17.2M | Buy |
|
|||||
|
2020
Q3 | $5.93M | Buy |
|
|||||
|
2020
Q2 | $7.79M | Buy |
|